JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, cilt.107, sa.1, ss.17-29, 2017 (SCI-Expanded)
Background: Intralesional epidermal growth factor (EGF) has been available as a medication in Turkey since 2012. We present the results of our experience using intralesional EGF in Turkey for patients with diabetic foot wounds.